The effects of the Cardamom aroma on the nausea and vomiting induced by chemotherapy

The effect of Cardamom aromatherapy on nausea and vomiting induced by chemotherapy in cancerous patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013071013936N1

Enrollment

Registered

2013-12-06

Start date

2013-12-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant neoplasm. Malignant neoplasms

Interventions

Intervention 1: The patients in the control group will receive the placebo. In order to prepare the placebo, two 2" × 2" gas pads will be soaked with 2 ml of distilled water put in a zipper plastic ba

Placebo

Treatment - Other

The patients in the control group will receive the placebo. In order to prepare the placebo, two 2" × 2" gas pads will be soaked with 2 ml of distilled water put in a zipper plastic bag. The patients

The patients in the experimental group will receive the essential oil of cardamom. In order to prepare the essential oil of cardamom, two 2" × 2" gas pads will be soaked with 2 drops of essential oil

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 18-65 years old; having a healthy olfactory; no history of asthma; no allergies to herbal essences; no history of chronic obstructive pulmonary disease; absence nausea due to the other reason verified by the physician; expression nausea after starting chemotherapy in the acute phase. Exclusion criterion: vomiting without nausea before the intervention protocol.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The severity of nausea induced by chemotherapy. Timepoint: Before the experiment, 5 minutes after the first intervention, and 5 minutes after second intervention. Method of measurement: Visual Analog Scale (VAS).	—

Secondary

Measure	Time frame
Number of vomiting. Timepoint: In the acute phase after research protocol intervention. Method of measurement: Frequency and/or multiple-choice questionnaire.;Number of retching. Timepoint: In the acute phase of chemotherapy after protocol implementation. Method of measurement: Frequency and/or multiple-choice questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Khalili

Hamadan, University of Medical Sciences

z.khalili@umsha.ac.ir+98 81 1838 0319

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026